(Q44621426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Voriconazole salvage treatment of invasive candidiasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

L Ostrosky-Zeichner

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

A M L Oude Lashof

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

B J Kullberg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

17 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

651-655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

20 December 2019

cites work

1 reference

12 December 2020

Epidemiology of opportunistic invasive mycoses.

1 reference

12 December 2020

International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group

1 reference

12 December 2020

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

1 reference

12 December 2020

Fungal infections in patients undergoing blood and marrow transplantation

1 reference

12 December 2020

Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model

1 reference

12 December 2020

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

12 December 2020

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Par

1 reference

12 December 2020

Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study

1 reference

12 December 2020

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

1 reference

12 December 2020

Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.

1 reference

12 December 2020

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

1 reference

12 December 2020

The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapy

1 reference

12 December 2020

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

12 December 2020

Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

1 reference

12 December 2020

Epidemiology of nosocomial fungal infections, with emphasis on Candida species

1 reference

12 December 2020

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens

1 reference

12 December 2020

Candidemia in intensive care unit patients: Risk factors for mortality

1 reference

12 December 2020

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

12 December 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

12 December 2020

Overview of systemic fungal infections

1 reference

12 December 2020

Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients

1 reference

12 December 2020

Antifungal pharmacodynamics: review of the literature and clinical applications

1 reference

12 December 2020

Review of the safety and efficacy of voriconazole

1 reference

12 December 2020

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

1 reference

12 December 2020

10.1007/S10096-003-1014-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14564539%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference